|
|
|
Insider
Information: |
Velleca Mark A. |
Relationship: |
|
City: |
Research Triangle Park |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
162,522 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,024,792 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
162,522 |
|
|
Total
Value |
$1,024,792 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
G1 Therapeutics Inc |
GTHX |
|
2023-08-08 |
116,000 |
2017-12-18 |
0 |
Premium* |
|
Black Diamond Therapeutics, Inc. |
BDTX |
|
2023-09-15 |
46,522 |
2022-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
88 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BDTX |
Black Diamond Therapeutic... |
|
|
2023-06-16 |
4 |
A |
$2.10 |
$18,751 |
D/D |
8,929 |
41,314 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
|
|
2023-08-08 |
4 |
OE |
$0.30 |
$23,156 |
D/D |
60,000 |
118,714 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
|
|
2023-08-08 |
4 |
AS |
$2.00 |
$119,974 |
D/D |
(60,000) |
116,000 |
0 |
% |
|
BDTX |
Black Diamond Therapeutic... |
PRESIDENT & CEO |
|
2023-09-15 |
4 |
A |
$3.60 |
$18,749 |
D/D |
5,208 |
46,522 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2017-12-18 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2017-12-18 |
4 |
AS |
$20.01 |
$150,106 |
D/D |
(7,500) |
0 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-01-16 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-01-16 |
4 |
AS |
$22.99 |
$172,395 |
D/D |
(7,500) |
0 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-02-15 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-02-15 |
4 |
AS |
$20.00 |
$150,015 |
D/D |
(7,500) |
0 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-03-15 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-03-15 |
4 |
AS |
$38.20 |
$286,466 |
D/D |
(7,500) |
0 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-04-16 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-04-16 |
4 |
AS |
$35.95 |
$269,971 |
D/D |
(7,500) |
0 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-05-15 |
4 |
AS |
$46.17 |
$347,064 |
D/D |
(7,500) |
0 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-05-15 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-05-31 |
4 |
OE |
$0.39 |
$3,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-06-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
9,000 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-07-16 |
4 |
OE |
$3.72 |
$18,600 |
D/D |
5,000 |
14,000 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-07-16 |
4 |
AS |
$41.86 |
$210,313 |
D/D |
(5,000) |
9,000 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-08-15 |
4 |
AS |
$55.33 |
$279,378 |
D/D |
(5,000) |
9,000 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-08-15 |
4 |
OE |
$3.72 |
$18,600 |
D/D |
5,000 |
14,000 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-09-17 |
4 |
OE |
$3.72 |
$18,600 |
D/D |
5,000 |
14,000 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-09-17 |
4 |
AS |
$65.74 |
$331,549 |
D/D |
(5,000) |
9,000 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
President and CEO |
|
2018-10-11 |
4 |
OE |
$0.39 |
$3,900 |
D/D |
10,000 |
19,000 |
0 |
- |
|
88 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|